MTCH2 and colorectal carcinoma: We found that MTCH2 inhibition markedly increased Fe2+, ROS, MDA, and lipid peroxidation levels of CRC cells, which could be reversed by treatment with Fer‐1 (Figure 3C–E; Figure S3B,C, Supporting Information).